Technology Foundation to Accelerate
and Scale Product Development

  • Alexion Boehringer Ingelheim CSL Emmes GSK Moderna

“Our strategic partnership with Veeva expands our capacity to leverage innovative technology and enhances our ability to deliver value to patients and all our stakeholders – this is key to how we measure success.”

-Robert M Davis, Chief Executive Officer and President, Merck

Read the Press Release

Greater Efficiency and Innovation

LEO
Streamlining Product Development with a Unified Platform

TRACON
Reducing Clinical Trial Cost by Connecting Systems

Idorsia
Why Idorsia Standardized on Clinical, Quality, and Regulatory

CSL
CSL Behring Breaks Down Business Silos with Veeva Development Cloud

Alexion
Alexion Supports Rapid Growth with Veeva Development Cloud

Boehringer Ingelheim
Boehringer Ingelheim Selects Veeva Development Cloud Worldwide to Bring Innovative Therapies to Patients Faster

Lysarc
LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments

Emmes
Emmes Standardizes on Veeva Development Cloud to Streamline Product Development

Gilead, AbbVie
Best Practices for Bringing Acquired Companies into a Veeva Environment

Streamline Cross-Functional Business Processes with Vault Connections

Vault Quality to RIM

How Moderna is Automating Change Control and Variation Management

UCB Streamlines Change Control and Variation Management

Vault RIM to Clinical Operations

Cerevel Bridges Gap Between Regulatory and Clinical

UroGen Pharma Streamlines Clinical and Regulatory Operations

Vault RIM to PromoMats

Pacira Explores Commercial and Regulatory Connection to Streamline Promotional Material Submissions

Vault Connections Live Discussions: Register here

Interested in learning more about how Veeva can help?

Contact us